- Home
- PWOD vs YMAB Comparison
PWOD vs YMAB Comparison
Compare PWOD & YMAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PWOD
- YMAB
- Stock Information
- Founded
- PWOD 1934
- YMAB 2015
- Country
- PWOD United States
- YMAB United States
- Employees
- PWOD N/A
- YMAB N/A
- Industry
- PWOD Major Banks
- YMAB Biotechnology: Pharmaceutical Preparations
- Sector
- PWOD Finance
- YMAB Health Care
- Exchange
- PWOD Nasdaq
- YMAB Nasdaq
- Market Cap
- PWOD 234.1M
- YMAB 270.5M
- IPO Year
- PWOD N/A
- YMAB 2018
- Fundamental
- Price
- PWOD $29.65
- YMAB $5.72
- Analyst Decision
- PWOD
- YMAB Strong Buy
- Analyst Count
- PWOD 0
- YMAB 10
- Target Price
- PWOD N/A
- YMAB $21.10
- AVG Volume (30 Days)
- PWOD 11.6K
- YMAB 528.2K
- Earning Date
- PWOD 01-29-2025
- YMAB 03-04-2025
- Dividend Yield
- PWOD 4.20%
- YMAB N/A
- EPS Growth
- PWOD 0.64
- YMAB N/A
- EPS
- PWOD 2.35
- YMAB N/A
- Revenue
- PWOD $68,377,000.00
- YMAB $84,553,000.00
- Revenue This Year
- PWOD N/A
- YMAB $6.41
- Revenue Next Year
- PWOD N/A
- YMAB $18.15
- P/E Ratio
- PWOD $12.97
- YMAB N/A
- Revenue Growth
- PWOD 6.11
- YMAB N/A
- 52 Week Low
- PWOD $17.01
- YMAB $5.60
- 52 Week High
- PWOD $34.56
- YMAB $20.90
- Technical
- Relative Strength Index (RSI)
- PWOD 38.00
- YMAB 35.08
- Support Level
- PWOD $31.04
- YMAB $5.60
- Resistance Level
- PWOD $31.56
- YMAB $6.57
- Average True Range (ATR)
- PWOD 0.53
- YMAB 0.38
- MACD
- PWOD -0.14
- YMAB 0.10
- Stochastic Oscillator
- PWOD 0.00
- YMAB 11.43
About PWOD Penns Woods Bancorp Inc.
Penns Woods Bancorp Inc is the bank holding company for Jersey Shore State Bank and Luzerne Bank. The banks serve customers in North Central and North Eastern Pennsylvania through their retail banking, commercial banking, mortgage services and financial services divisions. The Banks are engaged in commercial and retail banking which includes the acceptance of time, savings, and demand deposits, the funding of commercial, consumer, and mortgage loans, and safe deposit services. Utilizing a branch office network, ATMs, Internet, and telephone banking delivery channels, the Banks deliver their products and services to the communities residing in.
About YMAB Y-mAbs Therapeutics Inc.
Y-mAbs Therapeutics Inc is a commercial-stage biopharmaceutical company. It is mainly engaged in the development and commercialization of novel, antibody-based therapeutic products for the treatment of cancer. DANYELZA, is the first FDA-approved product of the company which is a recombinant humanized immunoglobulin G, subtype 1k, or IgG1k, monoclonal antibody or mAb that targets ganglioside GD2, which is expressed in various neuroectoderm-derived tumors and sarcomas.